Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like 9 devices that could revolutionize current treatments May 13, 2019 Rare Genetic Diseases” panel at the MIXiii-BIOMED conference (Hebrew) May 13, 2018 Israeli startup seeks to boost bone renewal and allow targeted drug delivery May 16, 2019